KELSEY RADER: Open Payments
NPI 1104479013 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 33 payments from 11 companies in 2025. Trend: 2023 $298 · 2024 $631 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $239 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Corium, LLC | 3 | $43 |
| Novo Nordisk Inc | 1 | $32 |
| Organon LLC | 1 | $28 |
| Lundbeck LLC | 2 | $28 |
| Corcept Therapeutics | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Tris Pharma Inc | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, Azstarys, Ozempic, NEXPLANON, REXULTI, Korlym, Jornay PM.
Industry payments across IN — which companies pay providers there.
